Another step forward in blood-based diagnostics for Alzheimer’s disease

Measurement of phosphorylated tau protein in blood plasma allows Alzheimer’s disease to be distinguished from other neurological diseases and may assist in disease detection during the prodromal stage.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2020-03, Vol.26 (3), p.314-316
Hauptverfasser:	Bateman, Randall J., Barthélemy, Nicolas R., Horie, Kanta
Format:	Artikel
Sprache:	eng
Schlagworte:	631/45/612/1221 692/617/375/132/1283 Alzheimer Disease Alzheimer's disease Amyloid beta-Peptides Amyloid beta-protein Biomarkers Biomedical and Life Sciences Biomedicine Blood Blood plasma Cancer Research Committees Cooking Diagnosis Disease detection Food Frontotemporal Dementia Frontotemporal Lobar Degeneration Health aspects Humans Infectious Diseases Medical examination Metabolic Diseases Molecular Medicine Neurodegenerative diseases Neurological diseases Neurosciences News & Views news-and-views Nonprofit organizations Nutrition Pathology Physiological aspects Plasma Potassium Preventive medicine Proteins Salt Tau protein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Measurement of phosphorylated tau protein in blood plasma allows Alzheimer’s disease to be distinguished from other neurological diseases and may assist in disease detection during the prodromal stage.
ISSN:	1078-8956 1546-170X
DOI:	10.1038/s41591-020-0797-4